About us

Improving the healthcare experience with AI algorithms

Algorithms are at the heart of diagnostic medicine. Through this, healthcare organizations can be provided with pre-analyzed data on individual risk and deliver data science-driven medical care.

In order to prevent major serious diseases in, TALOS is developing a high-performance AI learning model through insights and research from experts in the field. It is our goal to help individuals increase disease awareness and healthcare institutions to increase screening efficiency for all.

With our team of top medical experts and professionals, our vision is to innovate the health care experience with medical artificial intelligence and spearhead the industry to create social and economic value.

The Creators of TALOS Corp.

Tackeun Kim, CEO

Former) Professor of Neurosurgery, Seoul National University Bundang Hospital

Graduated from Seoul National University

Current Director of Computing at the Korean Society for Digital Convergence Neurosurgery

Former Associate Professor of Neurosurgery, Seoul National University Bundang Hospital

Former Professor of Medical Artificial Intelligence Center, Seoul National University Bundang Hospital

Former Visiting Professor at KAIST Graduate School of Artificial Intelligence

Jin-Deok Joo, Deputy CEO

Professor of Neurosurgery, Jeju National University Hospital

Graduated from Chonnam National University

Current Assistant Professor of Neurosurgery at Jeju National University Hospital

Former Professor of Neurosurgery at Seoul National University Bundang Hospital

Our Journey

2021-03-29

Faculty Startup Approval

Obtained startup approval through faculty startup review by the Seoul National University Startup Review Committee

2021-05-06

TALOS Corp. Registration

Promoters: Tackeun Kim, Jin-deok Joo, Jaehyuk Heo, Sangjun Park, Jeonggil Jung

2021-08-10

Seed Round Investment

KRW 300M

2021-09-14

Seed Round Investment

KRW 200M

2022-03-11

22021 1st Datathon Bundang Seoul National University Hospital Big Data Center

Grand Prize (1st Place)

2022-03-11

Seoul National University Bundang Hospital K-Bio Health Selection of Projects Funding

Healthcare Innovation Park, K-Bio Center

2022-05-13

TIPS Selection

R&D period:2022.05~2024.04
AI-based cerebral cardiovascular disease risk assessment

2022-09-30

Selected for the Gangnam-gu Job Startup Hub Center

160 Yeoksam-ro, Gangnam-gu, Seoul, Korea Job Startup Hub Center

2022-11-02

Venture Certification

2022-12-01

Selected for TIPS startup commercialization

Agreement period: 2022.11 ~ 2023.08

ANRISK™ AI-based cerebral aneurysm risk prediction platform

2023-06-08

Participated in Medical Taiwan 2023

June 8th~10th

2023-07-25

2023 Healthcare Big Data Startup Competition

Grand Prize (Minister of Health and Welfare Award)

2023-08-30

CHALLENGE! K-Startup 2023 Innovation Startup League (General League)

Grand Prize (Minister of Startup Promotion Award)

2023-10-20

The 11th Pan Government Data Startup Competition

Grand Prize (Presidential Award)

2023-12

Series A Funding – 3.8 billion KRW

Premier Partners, BA Partners, Medinno Partners

2024-04-02

TALOS Corp. Logo Renewal

2024-05-31

LINA 50+ Awards

Creative Innovation – 1st place

2024-09-11

Participated in Medical Fair Asia 2024

September 11th~13th

Our Patents & Research Publications

  • Device and Method for Predicting Intracranial Aneurysm Risk

  • Apparatus for Predicting Intracranial Aneurysm Using Retinal Fundus Image and Method for Providing Intracranial Aneurysm Prediction Results Using the Same

  • Diagnostic Aids System for Obstructive Sleep Apnea Using Cephaloradiographs and Method for Providing Diagnostic Aids thereof

  • Diagnostic Aids Method and Device for Cardioembolic Cerebral Infarction Using Chest Radiographs

  • Device and Method for Identifying Anatomical Location Using Flexible Bronchoscopy Images
  • Prediction of intracranial Aneurysm Risk using Machine Learning​
    Scientific reports 10, no. 1 (2020): 1-10​

  • Validation of prediction algorithm for risk estimation of intracranial aneurysm development using real-world data​
    Scientific reports 13, (2023)​

  • Incidence and risk factors of intracranial aneurysm: a national cohort study in Korea​
    International Journal of Stroke 11, no. 8 (2016): 917-927

  • Machine learning for detecting moyamoya disease in plain skull radiography using a convolutional neural network​
    EBioMedicine 40 (2019): 636-642

  • Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia
    Journal of Neurosurgery 124, no. 6 (2016): 1788-1793​